(Date:5/21/2013)... Puroast® Low Acid Coffee has named former Johnson ... the Board. , Among the many key ... his more than 30-year career was as a member ... of Consumer Pharmaceuticals & Nutritionals and President of McNeil ... build the market for such brands as Splenda®, Lactaid®, ...
(Date:5/21/2013)... attack on glioblastoma brain tumor cells that uses a ... study to establish the proper dose level, researchers at ... Duke and tested in an ongoing phase 1 study, ... abundance of receptors that work like magnets drawing the ... , The investigational therapy, known as PVSRIPO, uses an ...
(Date:5/21/2013)... 21, 2013 Adeptia, a leading provider ... today announced it is the featured company in an ... Research. The report, “Adeptia Bets on Converged Cloud Integration ... company, its strategy, products, pricing, customers and competition. ... a framework for integration and process orchestration, especially when ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Depression can ... the changes brought about by the disorder can be ... has found that people with diabetes who are depressed ... having a severe low blood sugar (hypoglycemia) episode that ... diabetes who aren,t depressed. "Depression is a ...
(Date:5/21/2013)... long been known for their health benefits, and ... like anti-cancer drugs are delivered to specific tumor ... how to create nanoparticles using natural lipids derived ... them as drug delivery vehicles. UofL scientists Huang-Ge ... team today (May 21, 2013), published their findings ...
Breaking Medicine News(10 mins):Health News:Former Johnson & Johnson Executive Brian Perkins Named Chairman of Puroast® Coffee 2Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2